+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neurovascular Devices Market by Product Type (Flow Diversion Devices, Microcatheters, Neurovascular Coils), Indication (Arteriovenous Malformation, Intracranial Aneurysm, Intracranial Stenosis), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454977
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neurovascular Devices Market grew from USD 3.44 billion in 2024 to USD 3.71 billion in 2025. It is expected to continue growing at a CAGR of 7.38%, reaching USD 5.28 billion by 2030.

Redefining the Neurovascular Device Arena Through Precision Innovation and Strategic Market Positioning to Shape the Future of Patient Outcomes

The neurovascular devices sector is experiencing an unprecedented convergence of clinical need and technological innovation. With cerebrovascular disorders such as aneurysms and strokes becoming more prevalent due to aging demographics and lifestyle factors, there is a critical demand for advanced interventional therapies that can improve patient outcomes. This introduction sets the stage by examining how recent breakthroughs in materials science, imaging modalities, and engineering have coalesced to redefine the treatment landscape for neurovascular conditions.

As research continues to uncover new pathways for minimally invasive interventions, the industry has witnessed significant momentum in product development and regulatory approvals. Consequently, stakeholders across the value chain-from device manufacturers to healthcare providers-must navigate a complex environment of clinical trials, reimbursement frameworks, and evolving best practices. By elucidating the key drivers and dynamics at play, this section offers a foundational understanding of the market’s current state and the strategic imperatives required to thrive in a rapidly transforming arena.

Unveiling Paradigm Shifts in Neurovascular Device Development from Technological Breakthroughs to Patient-Centric Clinical Approaches that Accelerate Industry Evolution

Over the past decade, the neurovascular space has undergone transformative shifts driven by a synergy between technological advancements and clinical insights. Flow diversion technologies have emerged as a paradigm shift for treating complex aneurysms, while next-generation microcatheters now offer enhanced navigability through tortuous vascular paths. Simultaneously, the evolution of bioactive and hydrogel coils has broadened therapeutic options by improving occlusion rates and reducing recurrence risks.

Furthermore, the integration of digital health platforms and artificial intelligence into interventional planning has ushered in an era of personalized procedural guidance. Real-time imaging enhancements, coupled with data analytics, enable clinicians to anticipate complications and optimize device selection on a case-by-case basis. Consequently, these dual forces of device innovation and digital transformation are reshaping the competitive landscape, prompting collaborative ventures between established medtech firms and emerging startups to accelerate product pipelines.

Evaluating the Comprehensive Impact of the 2025 United States Tariffs on Neurovascular Device Supply Chains and Strategic Responses within a Globalized Marketplace

The implementation of United States tariffs on neurovascular device imports beginning in 2025 has introduced a new layer of complexity to global supply chains. Manufacturers reliant on cross-border sourcing of metallic alloys, polymer coatings, and precision components now face elevated production costs. As a result, procurement strategies have pivoted toward diversifying supplier networks and investigating regional manufacturing hubs to mitigate tariff-induced margin pressures.

In response, device developers are accelerating investments in domestic facilities to sustain cost competitiveness and ensure uninterrupted product availability. This shift carries strategic implications for contract negotiations, inventory management protocols, and pricing models. Moreover, the recalibration of global logistics flows has spurred stronger partnerships with third-party logistics providers, allowing for adaptive distribution strategies that align with the evolving regulatory and fiscal landscape. Consequently, industry participants are redefining their operational playbooks to maintain resilience and uphold clinical delivery standards under the new tariff regime.

Decoding Market Segmentation Insights across Product Types Indications End Users and Distribution Channels to Empower Strategic Decision-Making in Neurovascular Devices

A nuanced understanding of market segmentation reveals the diverse pathways through which neurovascular therapies reach patients. By product type, the market embraces flow diversion systems such as pipeline embolization, silk, and surpass platforms, complemented by microcatheters featuring hydrophilic and PTFE coatings. Therapeutic coil options span bare metal architectures, bioactive coatings, and hydrogel-infused designs, while stenting solutions balance braided and laser-cut configurations for vessel support.

When examining clinical indications, arteriovenous malformation treatments leverage advanced embolic agents like glue and onyx, whereas intracranial aneurysm management employs endovascular coiling, flow diversion, and stent-assisted techniques. Therapies for intracranial stenosis integrate balloon angioplasty with precision stenting, and ischemic stroke interventions utilize intraarterial thrombolysis alongside mechanical thrombectomy. End user analysis highlights ambulatory surgical centers-both hospital affiliated and independent-primary and tertiary hospitals, and specialty clinics focused on interventional radiology and neurology. Distribution channels range from direct sales through field representatives and hospital contracts to online platforms and third-party distributors spanning retail and wholesale networks.

Illuminating Regional Dynamics in the Americas EMEA and Asia-Pacific to Identify Growth Opportunities and Tailor Neurovascular Device Strategies for Diverse Markets

Regional dynamics play a pivotal role in shaping the trajectory of neurovascular device adoption and commercialization. In the Americas, robust healthcare infrastructure combined with favorable reimbursement policies has fostered early adoption of innovative therapies. North American centers of excellence are leading clinical research initiatives, catalyzing widespread acceptance of cutting-edge interventional solutions.

Meanwhile, the Europe, Middle East & Africa region is characterized by a mosaic of regulatory frameworks and diverse payer systems. Strategic collaborations with regional regulatory bodies and targeted clinical trials have become essential to navigate this heterogeneous environment. In addition, emerging markets within the region are demonstrating growing demand for cost-effective devices that can be integrated into high-volume treatment settings.

Asia-Pacific stands out for its rapid healthcare investment, expanding middle-class patient base, and government-driven initiatives to upgrade neurovascular care capabilities. Partnerships between global device developers and local manufacturers are accelerating technology transfer, thus enabling tailored solutions that balance performance with affordability. Consequently, a regionalized market approach is critical to capture these differentiated growth vectors.

Profiling Leading Innovators and Strategic Players Shaping the Neurovascular Device Landscape through R&D Alliances Partnerships and Competitive Differentiation

Key industry players continue to shape the competitive landscape through strategic R&D collaborations, acquisitions, and differentiated product portfolios. Leading medical technology manufacturers are investing heavily in next-generation materials and device architectures to secure intellectual property advantages. At the same time, nimble startups are driving innovation by focusing on niche applications and forging partnerships with academic institutions for accelerated proof-of-concept validation.

Moreover, alliances between device companies and imaging technology providers are yielding integrated platforms that enhance real-time procedural guidance. These ecosystem plays not only bolster clinical confidence but also create recurring revenue models tied to consumables and service offerings. As these competitive dynamics unfold, market participants are prioritizing cross-functional teams that can align engineering, regulatory, and commercial capabilities to outpace rivals and capture emerging clinical segments.

Actionable Strategies for Industry Leaders to Optimize Market Positioning Enhance Clinical Adoption and Drive Sustainable Growth in the Neurovascular Devices Sector

To capitalize on emerging opportunities, industry leaders should prioritize a multifaceted strategy that integrates clinical evidence generation with strategic partnerships. Investing in longitudinal outcome studies will substantiate device efficacy and drive payer reimbursement discussions. Concurrently, establishing alliances with regional manufacturing partners can streamline supply chains and reduce exposure to tariff fluctuations.

In addition, targeted educational initiatives for interventionalists and multidisciplinary care teams will accelerate adoption curves and reinforce best practices. Leveraging digital platforms for remote proctoring and real-time analytics can differentiate value propositions and foster deeper customer engagement. Finally, a balanced portfolio approach-combining high-growth innovations with core product optimizations-will enable sustainable revenue expansion and resilience amid evolving regulatory and economic environments.

Comprehensive Research Methodology Combining Primary Interviews Secondary Data Analysis and Rigorous Validation to Ensure Analytical Rigor and Insight Integrity

This research leverages a rigorous blend of primary and secondary data sources to ensure analytical robustness. Primary inputs were gathered through in-depth interviews with neurosurgeons, interventional neuroradiologists, hospital procurement directors, and device engineers. These qualitative insights were complemented by secondary analysis of peer-reviewed journals, regulatory filings, clinical trial registries, and industry white papers.

Triangulation methods were employed to cross-validate data points, ensuring consistency across multiple information streams. Quantitative metrics were synthesized using statistical tools, while expert validation sessions provided real-world contextualization of emerging trends. In addition, ongoing consultation with advisory boards comprising clinical and market experts reinforced the credibility of key findings, making certain that the insights presented align with evolving practice standards and technological advancements.

Conclusion Synthesizing Key Insights on Innovation Market Dynamics and Strategic Imperatives to Guide Stakeholders in the Neurovascular Devices Domain

In summary, the neurovascular devices market is poised at a critical inflection point defined by technological breakthroughs, regulatory shifts, and evolving clinical paradigms. The convergence of advanced flow diversion systems, next-generation microcatheters, and intelligent digital platforms is reshaping treatment pathways and opening new patient cohorts to minimally invasive interventions.

Looking ahead, resilience to trade policy changes, agile supply chain strategies, and tailored regional approaches will determine market leadership. Equally important will be the strategic cultivation of clinical evidence and partnerships that drive procedural confidence. By synthesizing these elements, stakeholders can navigate the complexities of the landscape, capitalize on growth vectors, and ultimately improve patient outcomes on a global scale.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Flow Diversion Devices
      • Pipeline Embolization Devices
      • Silk Devices
      • Surpass Devices
    • Microcatheters
      • Hydrophilic Coated
      • PTFE Coated
    • Neurovascular Coils
      • Bare Metal Coils
      • Bioactive Coils
      • Hydrogel Coils
    • Neurovascular Stents
      • Braided Stents
      • Laser Cut Stents
  • Indication
    • Arteriovenous Malformation
      • Glue Embolic Agents
      • Onyx
    • Intracranial Aneurysm
      • Endovascular Coiling
      • Flow Diversion
      • Stent Assisted Coiling
    • Intracranial Stenosis
      • Balloon Angioplasty
      • Stenting
    • Ischemic Stroke
      • Intraarterial Thrombolysis
      • Mechanical Thrombectomy
  • End User
    • Ambulatory Surgical Centers
      • Hospital Affiliated Centers
      • Independent Centers
    • Hospitals
      • Primary Hospitals
      • Tertiary Care Hospitals
    • Specialty Clinics
      • Interventional Radiology Clinics
      • Neurology Clinics
  • Distribution Channel
    • Direct Sales
      • Field Representatives
      • Hospital Contracts
    • Online Sales
      • E Commerce Platforms
      • Manufacturer Websites
    • Third Party Distributors
      • Retail Distributors
      • Wholesale Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra, Inc.
  • Terumo Corporation
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Cordis LLC
  • Siemens Healthineers AG
  • Asahi Intecc Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of next-generation bioresorbable stents reducing long-term vessel inflammation
5.2. Integration of artificial intelligence and machine learning in neurovascular intervention planning
5.3. Development of microcatheter technologies enabling access to distal cerebral vasculature
5.4. Expansion of thrombectomy device indications to treat large vessel acute ischemic strokes
5.5. Emergence of polymer-coated coils for enhanced aneurysm occlusion durability in complex anatomies
5.6. Growth of telemedicine-enabled remote proctoring for complex neurointerventional procedures
5.7. Advancements in patient-specific 3D-printed vascular models to optimize surgical outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurovascular Devices Market, by Product Type
8.1. Introduction
8.2. Flow Diversion Devices
8.2.1. Pipeline Embolization Devices
8.2.2. Silk Devices
8.2.3. Surpass Devices
8.3. Microcatheters
8.3.1. Hydrophilic Coated
8.3.2. PTFE Coated
8.4. Neurovascular Coils
8.4.1. Bare Metal Coils
8.4.2. Bioactive Coils
8.4.3. Hydrogel Coils
8.5. Neurovascular Stents
8.5.1. Braided Stents
8.5.2. Laser Cut Stents
9. Neurovascular Devices Market, by Indication
9.1. Introduction
9.2. Arteriovenous Malformation
9.2.1. Glue Embolic Agents
9.2.2. Onyx
9.3. Intracranial Aneurysm
9.3.1. Endovascular Coiling
9.3.2. Flow Diversion
9.3.3. Stent Assisted Coiling
9.4. Intracranial Stenosis
9.4.1. Balloon Angioplasty
9.4.2. Stenting
9.5. Ischemic Stroke
9.5.1. Intraarterial Thrombolysis
9.5.2. Mechanical Thrombectomy
10. Neurovascular Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Hospital Affiliated Centers
10.2.2. Independent Centers
10.3. Hospitals
10.3.1. Primary Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Specialty Clinics
10.4.1. Interventional Radiology Clinics
10.4.2. Neurology Clinics
11. Neurovascular Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Field Representatives
11.2.2. Hospital Contracts
11.3. Online Sales
11.3.1. E Commerce Platforms
11.3.2. Manufacturer Websites
11.4. Third Party Distributors
11.4.1. Retail Distributors
11.4.2. Wholesale Distributors
12. Americas Neurovascular Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurovascular Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurovascular Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Stryker Corporation
15.3.3. Johnson & Johnson Services, Inc.
15.3.4. Penumbra, Inc.
15.3.5. Terumo Corporation
15.3.6. Boston Scientific Corporation
15.3.7. MicroPort Scientific Corporation
15.3.8. Cordis LLC
15.3.9. Siemens Healthineers AG
15.3.10. Asahi Intecc Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEUROVASCULAR DEVICES MARKET: RESEARCHAI
FIGURE 24. NEUROVASCULAR DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. NEUROVASCULAR DEVICES MARKET: RESEARCHCONTACTS
FIGURE 26. NEUROVASCULAR DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PIPELINE EMBOLIZATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PIPELINE EMBOLIZATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SILK DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SILK DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SURPASS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SURPASS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PTFE COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PTFE COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BARE METAL COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BARE METAL COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BIOACTIVE COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BIOACTIVE COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HYDROGEL COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HYDROGEL COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BRAIDED STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BRAIDED STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LASER CUT STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LASER CUT STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY GLUE EMBOLIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY GLUE EMBOLIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONYX, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONYX, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENT ASSISTED COILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENT ASSISTED COILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRAARTERIAL THROMBOLYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRAARTERIAL THROMBOLYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FIELD REPRESENTATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FIELD REPRESENTATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITAL CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITAL CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY RETAIL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY RETAIL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 214. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 215. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 216. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 217. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 218. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 219. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 220. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 221. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 226. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 227. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 228. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 229. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 230. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 231. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 234. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 235. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 238. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 239. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 242. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 243. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 244. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 245. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 246. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 262. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 263. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 264. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 265. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 278. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 279. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 280. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 281. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INTRACRANIAL STENOSIS, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra, Inc.
  • Terumo Corporation
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Cordis LLC
  • Siemens Healthineers AG
  • Asahi Intecc Co., Ltd.

Table Information